What is FITX worth, really? (I needed to re-post due

New Post Public Reply Private Reply Replies (0) Message Board
UConnGuy
What is FITX worth, really?

(I needed to re-post due to a glaring error. Thanks to the eagle-eyed FITXer kbad.)

Several days ago I posted a valuation (copied from privateequityguru) which posited the pps based on different scenarios. While I think that model is still valid, I have began to wonder about its limitations. (To be honest, pps on the pennies can baffling because they don’t seem to follow the same rules as my other stocks - i.e. good news comes out, stock jumps.) I began to wonder where this stock should be, or better yet could be. (Please feel free to add to this list of queries.)

What should a stock be worth that has the “largest and most advanced” legal marijuana production facility in the world, a “$20 million facility will churn out pot like other factories churn out aspirin?” A company where $5 BILLION in sales is just a start, and the demand will only grow in the coming years, and may never decline? (Think about that $5 billion in sales within a year or two!) If trends continue, legally and socially, $25 billion in sales will be reached in 7 - 10 years with the addition of new facilities (my estimate).

What is a company worth that is at the forefront of all the aspects of a breakout industry about to take North America by storm? An industry that will produce more wealth than the tobacco industry did, once the medical and recreational laws settle out (my hypothesis).

What is a company worth that appoints the best talent it can attract in all the major areas of (its) business? What if that company goes out if its way to avoid the legal pitfalls of it competitors? What if that company had no real competitors? What if that company is led by a team with the vision to do the right things, the right way? (Remember Warren Buffet says to buy a stock based on management more than anything else.)

I cannot even begin to guess what will come from the hemp and medical research/pharmaceutical side of this company.

So,,,

The below projection goes right out the window. I guess that if everything falls in place even close to what is expected/planned, if just half of it happens add a zero to the pps/earnings numbers below. Yep, multiply by 10.

(copied from privateequityguru)
If FITX produces just 100,000 pounds of MJ in it's first full year....less than 1/10 (one tenth) of the 1.3 million pounds.....at a sales price of just $2,500 per pound...the total revenue will be $250,000,000 (two hundred and fifty million dollars)....at a 60-70% profit margin, that will be a profit of $150,000,000 to $200,000,000 (one hundred and fifty million dollars to two hundred million dollars).

But assuming the 60% holds true as we ramp up, FITX total authorized share count of 3,500,000,000.....the earnings ($150,000,000 divided by 3,500,000,000) per share would be $0.043 (four point three cents) per share. Then, with a modest P/E (price / earnings) ratio of:

PE PPS
25 $1.07 (25 P/E times $0.043 earnings per share).
30 $1.29 (30 P/E times $0.043 earnings per share).
35 $1.50 (35 P/E times $0.043 earnings per share).
40 $1.72 (40 P/E times $0.043 earnings per share).
45 $1.93 (45 P/E times $0.043 earnings per share).
50 $2.15 (50 P/E times $0.043 earnings per share).
55 $2.36 (55 P/E times $0.043 earnings per share).
60 $2.58 (60 P/E times $0.043 earnings per share).

That is at 10% of the proposed production, without a share repurchase, without adding in HEMP Tech or the supplemental products....

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 1

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
Rackspace Lawsuit Deadline: Investors Must Take Action

Updated Category News Views 2

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Continue Reading
Fujifilm's New 400mm Lens: A Game Changer?

Updated Category News Views 0

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Continue Reading
Greenberg Traurig Shines in 2026 Palm Beach Attorney List

Updated Category News Views 1

Legal Eagles Soar in the Sunshine State Right out of the gate, it looks like Greenberg Traurig's West Palm Beach office is getting all the spotlight. Twenty-one of their legal hotshots have clinched spots on Palm Beach Illustrated's 2026 'Top Lawyers' list. For those keeping score, that's a hefty nod in this competitive market. A Closer Look at the Selection Process Now,...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
October 15 Marks Prologis Q3 2026 Results Call

Updated Category News Views 2

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 0

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 0

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
LG Electronics Unveils Smart Home Innovations at IFA

Updated Category News Views 1

Alright, let's dive into this world of shiny new gadgets that LG Electronics has trotted out at the IFA 2026. As European homes get cozier, folks aren't just after any appliance—they're seeking ones that blend smarts, efficiency, and style. So, LG's rolling out seven of their latest and supposedly greatest home appliances, hoping they'll hit the mark with the modern...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading

Top 5 Most Recently Viewed Articles

VersaBank Appoints New Leadership to Accelerate U.S. Growth

Updated Category News Views 301

Exciting Leadership Changes at VersaBank VersaBank (TSX: VBNK) (NASDAQ: VBNK), a leader in North American digital banking and cybersecurity solutions, has recently announced a significant transition within its executive team. This strategic move involves transferring key team members responsible for the success of the Receivable Purchase Program (RPP) to the United...

Continue Reading
FuelPositive Secures Funds for Sustainable Technology Growth

Updated Category News Views 57

FuelPositive Completes Private Placement Successfully FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) has successfully completed a significant non-brokered private placement, raising a total of $490,878. This was achieved by issuing 8,925,055 units at a price of $0.055 per unit. Each unit consists of one common share along with a share purchase warrant, which can be...

Continue Reading
Recent NYSE Group Short Interest Data and Insights

Updated Category News Views 83

NYSE Group's Latest Short Interest Overview The latest short interest data offers valuable insights into trading behaviors and market sentiment related to various securities. A recent report from NYSE, which was finalized with figures as of the mid-September settlement date, highlights shifts in market dynamics. For investors, grasping these trends is crucial for...

Continue Reading
Bank of America Predicts Metal Prices to Fluctuate by 2025

Updated Category News Views 1223

Bank of America’s Insights on Metals Market for 2025 Bank of America (BofA) analysts are painting a picture of a metals and minerals market that could experience significant fluctuations as we approach 2025. Various factors are expected to play a crucial role, including shifting trade policies, supply challenges, and evolving demand patterns. Price Forecasts for...

Continue Reading
Barington Capital Pressures TriMas to Review Strategic Options

Updated Category News Views 290

Strategic Review Urged by Activist Investor By Svea Herbst-Bayliss Activist investor Barington Capital Group is advocating that TriMas initiate a comprehensive strategic review, considering various options such as a potential sale of the entire company. The firm argues in a recent letter that engaging a financial adviser should take precedence over the search for a new...

Continue Reading